Public Access to the Human Genome Sequence
Public databases shaped genomic research without resolving every question of ownership and privacy.
The Human Genome Project was an international public research effort. In 2001, public collaborators released a draft sequence alongside work by the private company Celera; the project was declared complete in 2003. Public access helped researchers build on shared reference data.
The sequence was not a complete map of every person's biology, nor did public release settle all legal and ethical issues. Genetic privacy, consent, interpretation, patent policy, and unequal access to resulting treatments remain important concerns.
If key reference data had been kept behind exclusive licenses, some research might have faced additional costs or delays. Public institutions and private companies would still have pursued research, and open access alone cannot ensure fair medical benefits.
Knowledge can be broadly available while the tools built from it remain unevenly controlled. The relevant question is not only who owns data, but who can use it, who is exposed by it, and who benefits from the medicine that follows.
Knowledge can be broadly available while the tools built from it remain unevenly controlled.
When I call scientific data a public good, what protections and fair access should accompany its use?